top of page

next-generation recombinant protein production

the platform

=

Biobank with in-house analysis of hundreds of unconventional microbial species

+

AI and LLM systems enabling proprietary genetic tool kit formulation

matching proteins 
with optimal
microorganisms

protein
production

In under 10 weeks, our platform enabled us to produce samples of some of the most challenging recombinant proteins.

talin

Protein forming a supersonic-shock absorbing material.

Industry: materials, sports, aerospace.

hEGF

Human epidermal growth factor, necessary for wound healing and skin health.

Industry: biocosmetics, biopharma.

lactoferrin
(human)

Glycosylated protein normally found in breast milk.

Industry: food, nutrition, biopharma.

ABOUT

HERlab is a synbio and AI startup that uses unconventional microorganisms and LLM to find and develop specialised microbial expression systems for complex protein production.

 

In our UK-based laboratory, we are working to scale up our recent successes with proteins that require human-like glycosylation and other human-origin proteins that have never been industrially produced before. 

We are looking for opportunities to help pharmaceutical, cosmetics, or protein engineering companies, that have novel or complex protein production requirements.

FUNDED RESEARCH OPPORTUNITIES

R&D collaborations with Japan
R&D collaborations with Germany

Please reach out to
aus.l@herlab.bio to discuss

Investors

image.png
image.png
G-Force logo.png
image.png
image.png
Leapsolve capital_edited.png
image.png
SUBSCRIBE

invest in the future

sign-up to get investment-round updates

Dei Drasutyte
CEO and Founder at HERlab

bottom of page